{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:41:40Z","timestamp":1788921700107,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Soluble cluster of differentiation 26 (sCD26) has a wide range of enzymatic functions affecting immunological, metabolic and vascular regulation. Diminished sCD26 concentrations have been reported in various autoimmune diseases and also in Myalgic Encephalomyelitis\/Chronic fatigue syndrome (ME\/CFS). Here we re-evaluate sCD26 as a diagnostic marker and perform a comprehensive correlation analysis of sCD26 concentrations with clinical and paraclinical parameters in ME\/CFS patients. Though this study did find significantly lower concentrations of sCD26 only in the female cohort and could not confirm diagnostic suitability, results from correlation analyses provide striking pathomechanistic insights. In patients with infection-triggered onset, the associations of low sCD26 with elevated autoantibodies (AAB) against alpha1 adrenergic (AR) and M3 muscarinic acetylcholine receptors (mAChR) point to a pathomechanism of infection-triggered autoimmune-mediated vascular and immunological dysregulation. sCD26 concentrations in infection-triggered ME\/CFS were found to be associated with activated T cells, liver enzymes, creatin kinase (CK) and lactate dehydrogenase (LDH) and inversely with Interleukin-1 beta (IL-1b). Most associations are in line with the known effects of sCD26\/DPP-4 inhibition. Remarkably, in non-infection-triggered ME\/CFS lower sCD26 in patients with higher heart rate after orthostatic challenge and postural orthostatic tachycardia syndrome (POTS) suggest an association with orthostatic regulation. These findings provide evidence\u00a0that the key enzyme sCD26 is linked to immunological alterations in infection-triggered ME\/CFS and delineate a different pathomechanism in the non-infectious ME\/CFS subset.<\/jats:p>","DOI":"10.3389\/fimmu.2021.644548","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T08:40:55Z","timestamp":1617698455000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Marvin","family":"Szklarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helma","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Sotzny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelka","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Wittke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif G.","family":"Hanitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"11","author":"Carruthers","year":"2003","journal-title":"J Chronic Fatigue Syndr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00412","article-title":"Estimating Prevalence, Demographics, and Costs of ME\/CFS Using Large Scale Medical Claims Data and Machine Learning","volume":"6","author":"Valdez","year":"2018","journal-title":"Front Pediatr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome - Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00012","article-title":"Onset Patterns and Course of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"7","author":"Chu","year":"2019","journal-title":"Front Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12967-018-1644-y","article-title":"Chronic viral infections in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"16","author":"Rasa","year":"2018","journal-title":"J Transl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.09.013","article-title":"Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome","volume":"52","author":"Loebel","year":"2016","journal-title":"Brain Behav Immun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12751","article-title":"Altered Structural Brain Networks Related to Adrenergic\/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome","volume":"30","author":"Fujii","year":"2020","journal-title":"J Neuroimaging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.bbih.2020.100107","article-title":"Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients \u2013 A validation study in plasma and cerebrospinal fluid from two Swedish cohorts","volume":"7","author":"Bynke","year":"2020","journal-title":"Brain Behav Immun - Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2017.04.010","article-title":"Comorbidity in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study","volume":"58","author":"Castro-Marrero","year":"2017","journal-title":"Psychosomatics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-019-1797-3","article-title":"Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study","volume":"17","author":"Tsai","year":"2019","journal-title":"J Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00578","article-title":"Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME\/CFS With Infectious Onset","volume":"11","author":"Steiner","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01033","article-title":"Neuroinflammation and Cytokines in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): A Critical Review of Research Methods","volume":"9","author":"VanElzakker","year":"2018","journal-title":"Front Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01634.x","article-title":"Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26\/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides","volume":"267","author":"Durinx","year":"2000","journal-title":"Eur J Biochem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13163","article-title":"Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4","volume":"194","author":"Casrouge","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03207-0","article-title":"Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26\/DPP4","volume":"77","author":"Lettau","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3082","article-title":"Enhancement of antigen-induced T-cell proliferation by soluble CD26\/dipeptidyl peptidase IV","volume":"91","author":"Tanaka","year":"1994","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609157200","article-title":"Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1","volume":"282","author":"Ohnuma","year":"2007","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.17-64","article-title":"Dipeptidyl peptidase-4 inhibitors have adverse effects for the proliferation of human T cells","volume":"63","author":"Kitagawa","year":"2018","journal-title":"J Clin Biochem Nutr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s002960100134","article-title":"Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis","volume":"21","author":"Cordero","year":"2001","journal-title":"Rheumatol Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/003655201750422675","article-title":"(DP IV, CD26) in patients with inflammatory bowel disease","volume":"36","author":"Hildebrandt","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"B22","article-title":"Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides","volume":"18","author":"Schonermarck","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e10817","DOI":"10.1371\/journal.pone.0010817","article-title":"Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV\/CD26","volume":"5","author":"Fletcher","year":"2010","journal-title":"PloS One"},{"key":"B24","first-page":"1","article-title":"A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes","volume":"8","author":"Porter","year":"2010","journal-title":"J Behav Neurosci Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12967-016-1010-x","article-title":"Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis\/chronic fatigue syndrome patients","volume":"14","author":"Fenouillet","year":"2016","journal-title":"J Transl Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0129898","DOI":"10.1371\/journal.pone.0129898","article-title":"B-Lymphocyte Depletion in Myalgic Encephalopathy\/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"B28","volume-title":"The Doctor\"s Guide to Chronic Fatigue Syndrome: Understanding, Treating and Living with CFIDS","author":"Bell","year":"1995"},{"key":"B29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jpsychores.2009.10.007","article-title":"Measuring fatigue in clinical and community settings","volume":"69","author":"Cella","year":"2010","journal-title":"J Psychosom Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"B31","first-page":"1","article-title":"The igraph software package for complex network research","volume":"1695","author":"Csardi GN","year":"2006","journal-title":"InterJournal Complex Syst"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2011.10.003","article-title":"Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an \u201cautoimmune\u201d orthostatic hypotension","volume":"6","author":"Yu","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e013602","DOI":"10.1161\/JAHA.119.013602","article-title":"Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies","volume":"8","author":"Gunning","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384921-2.00006-9","article-title":"Modulation of immune cell function by alpha(1)-adrenergic receptor activation","volume":"67","author":"Grisanti","year":"2011","journal-title":"Curr Top Membr"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)81609-4","article-title":"(CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences","volume":"336","author":"Hoffmann","year":"1993","journal-title":"FEBS Lett"},{"key":"B36","doi-asserted-by":"publisher","first-page":"100047","DOI":"10.1016\/j.bbih.2020.100047","article-title":"Research article IgG stimulated \u03b22 adrenergic receptor activation is attenuated in patients with ME\/CFS","volume":"3","author":"Hartwig","year":"2020","journal-title":"Brain Behav Immun - Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmet.2018.10.001","article-title":"Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition","volume":"29","author":"Varin","year":"2019","journal-title":"Cell Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature26138","article-title":"Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance","volume":"555","author":"Ghorpade","year":"2018","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0009-8981(75)90273-9","article-title":"Glycylprolyl beta-naphthylamidase activity in human serum","volume":"62","author":"Hino","year":"1975","journal-title":"Clin Chim Acta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110403","article-title":"Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence","volume":"11","author":"McCaughan","year":"1990","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s1707","article-title":"Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes","volume":"4","author":"Richter","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.890989","article-title":"DPP-4 inhibitors improve liver dysfunction in type 2 diabetes mellitus","volume":"20","author":"Kanazawa","year":"2014","journal-title":"Med Sci Monit"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e62008","DOI":"10.1371\/journal.pone.0062008","article-title":"Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells","volume":"8","author":"Raschke","year":"2013","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/diagnostics9020041","article-title":"Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) from an Analytic Cross-Sectional Study","volume":"9","author":"Nacul","year":"2019","journal-title":"Diagn (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.02.043","article-title":"Cardiac origins of the postural orthostatic tachycardia syndrome","volume":"55","author":"Fu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000160356.97313.5D","article-title":"Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"key":"B48","article-title":"Reduction of serum soluble CD26\/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus","volume":"29","author":"Kobayashi","year":"2002","journal-title":"J Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-017-1263-z","article-title":"The European ME\/CFS Biomarker Landscape project: an initiative of the European network EUROMENE","volume":"15","author":"Scheibenbogen","year":"2017","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.644548\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T08:41:01Z","timestamp":1617698461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.644548\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2021.644548"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.644548","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"article-number":"644548"}}